Search research articles
Contact Us
Filters
Showing results (681-690 of 725) with videos related to
Page
of 73
Sort By:
Cancer Research
|
February 15, 2024
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, et al.
Cancer Discovery
|
March 12, 2021
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
Giorgia Foggetti, Chuan Li, Hongchen Cai, et al.
JCI Insight
|
August 26, 2025
B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome
Roméo Milan Diana, Benjamin Jolivet, Jean-Baptiste Vincourt, et al.
ACS Pharmacology & Translational Science
|
October 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction
John Lupisella, Stéphane St-Onge, Marilyn Carrier, et al.
Journal of Medicinal Chemistry
|
July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex
Xiaojun Zhang, Peter W Glunz, James A Johnson, et al.
ACS Medicinal Chemistry Letters
|
January 8, 2019
Potent Triazolopyridine Myeloperoxidase Inhibitors
Nicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
Ioannis P Trontzas, Mengni He, Anna Wurtz, et al.
Journal of Medicinal Chemistry
|
May 15, 2020
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
Yoshikazu Asahina, Nicholas R Wurtz, Kazuto Arakawa, et al.
EMBO Molecular Medicine
|
April 3, 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis
Andreas Margraf, Jianmin Chen, Marilena Christoforou, et al.
Journal of AOAC International
|
September 18, 1999
IUPAC collaborative trial study of a method to detect genetically modified soy beans and maize in dried powder
M Lipp, P Brodmann, K Pietsch, et al.
Page
of 73
Search research articles
Search
Showing results (681-690 of 725) with videos related to
Sort By:
Page
of 73
Cancer Research
|
February 15, 2024
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, et al.
Cancer Discovery
|
March 12, 2021
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response <i>In Vivo</i>
Giorgia Foggetti, Chuan Li, Hongchen Cai, et al.
JCI Insight
|
August 26, 2025
B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome
Roméo Milan Diana, Benjamin Jolivet, Jean-Baptiste Vincourt, et al.
ACS Pharmacology & Translational Science
|
October 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction
John Lupisella, Stéphane St-Onge, Marilyn Carrier, et al.
Journal of Medicinal Chemistry
|
July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex
Xiaojun Zhang, Peter W Glunz, James A Johnson, et al.
ACS Medicinal Chemistry Letters
|
January 8, 2019
Potent Triazolopyridine Myeloperoxidase Inhibitors
Nicholas R Wurtz, Andrew Viet, Scott A Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
Ioannis P Trontzas, Mengni He, Anna Wurtz, et al.
Journal of Medicinal Chemistry
|
May 15, 2020
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
Yoshikazu Asahina, Nicholas R Wurtz, Kazuto Arakawa, et al.
EMBO Molecular Medicine
|
April 3, 2025
Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis
Andreas Margraf, Jianmin Chen, Marilena Christoforou, et al.
Journal of AOAC International
|
September 18, 1999
IUPAC collaborative trial study of a method to detect genetically modified soy beans and maize in dried powder
M Lipp, P Brodmann, K Pietsch, et al.
Page
of 73